Lab Automation in Clinical Diagnostics Market Share

Statistics for the 2023 & 2024 Lab Automation in Clinical Diagnostics market share, created by Mordor Intelligence™ Industry Reports. Lab Automation in Clinical Diagnostics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Lab Automation in Clinical Diagnostics Industry

The Lab Automation in Clinical Diagnostics Market is highly competitive owing to multiple vendors providing automation to the domestic and international markets. The market appears to be moderately fragmented, with the significant vendors adopting strategies for mergers and acquisitions, strategic partnerships, among others, to expand their reach and stay competitive in the market. Some of the recent developments in the market are:

  • February 2021 - The Thermo Fisher Scientific Amplitude Solution is a new highly automated molecular diagnostic testing system capable of analyzing up to 8,000 COVID-19 specimens in 24 hours. Using the system, laboratories are rapidly scaling their COVID-19 testing workflows to the volumes needed to help reduce the spread of disease and restore economies and communities.
  • January 2020 - Hamilton Company announced that its latest automated liquid handling platform, the Microlab Prep, is available through their e-commerce website in the United States and Canada. The compact Microlab Prep provides complete walkaway convenience and effective liquid handling performance in workflows using 96- and 384-well microplates and other sample vessels.

Lab Automation in Clinical Diagnostics Market Leaders

  1. Thermo Fisher Scientific

  2. Danaher Corporation

  3. Hudson Robotics

  4. Becton Dickinson

  5. Synchron Lab Automation

*Disclaimer: Major Players sorted in no particular order

Lab Automation in Clinical Diagnostics Market

Lab Automation in Clinical Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)